Kaizen CFO/blog
Veterinary Sell-Side

QoE & Sell-Side Prep for Veterinary Practices


Veterinary consolidators have spent the last decade buying practices at multiples that make human medicine jealous. The prices are real. So is the diligence — and the first thing they normalize is what it costs to replace you at the exam table.

Veterinarian examining a dog during a checkup

What a buyer is really paying for

A veterinary buyer is paying for the practice's earnings after every doctor, including you, is paid a market production wage. In an owner-run hospital, your compensation and the practice's profit blur together, and normalizing DVM comp is the adjustment that moves adjusted EBITDA — and therefore the price — more than any other single line.

They're also paying for durability: wellness plans, the recheck and recall cadence, a bonded active-client base, and associate doctors who keep producing whether or not the owner is in the building. Recurring wellness-plan revenue and a practice that isn't one departure from a cliff are what justify the multiples this sector is known for.

EBITDA is what the multiple attaches to, but for a veterinary practice the DVM-comp normalization and associate coverage decide whether that EBITDA survives the buyer's model.

Add-backs and DVM dependency

The usual legitimate add-backs apply — personal vehicles, a relative on payroll, one-time equipment, conference travel that leaned heavily on the word conference. Each raises adjusted EBITDA when documented well. But the dominant adjustments are compensation and dependency: normalizing every doctor's pay to a market production rate, and showing that the practice's revenue doesn't hinge entirely on the owner-vet's personal caseload.

We normalize DVM and staff compensation, correct any wellness-plan deferral, and quantify how production is spread across doctors — so a consolidator's biggest concerns are answered with numbers before they're even raised.

How Kaizen runs it

We run a diligence-grade scan of your trailing twelve months, normalize doctor and staff compensation, restate revenue into recurring wellness-plan versus fee-for-service, correct wellness-plan deferred revenue, and build the Reported-to-Adjusted EBITDA bridge a buyer's QoE firm will respect. You get a workbook, a narrative memo, and a clean-up list of the things to fix before the buyer's team finds them.

The goal: present earnings that already reflect market pay for every doctor, so a consolidator confirms your number instead of quietly rebuilding it.

What's included

  • Trailing-twelve-month Reported → Adjusted EBITDA bridge with support for every add-back
  • Doctor and staff compensation normalized to defensible market production rates
  • Revenue restated into recurring wellness-plan vs. fee-for-service and services vs. product/pharmacy
  • Wellness-plan deferred revenue corrected to match delivery
  • Production spread across doctors quantified — how much depends on the owner-vet
  • Active-client base and recall cadence quantified (buyers ask — have the answer ready)
  • Working-capital peg estimate so the closing true-up doesn't ambush you
  • Narrative QoE memo plus a defensible workbook you can hand to advisors
This pairs with the 1-2-3 CFO™ Reset if the books need work first — DVM-comp normalization only holds on a reconciled ledger.

Pricing

From $15,000one-time sell-side QoE engagement · scoped to size and book quality
8–12x EBITDAthe range quality veterinary practices have traded to consolidators in — defensible, doctor-normalized EBITDA is what supports it
Comp done rightevery doctor's pay normalized to market, so adjusted earnings survive the buyer's model
Fewer surprisesissues found and fixed before diligence, not renegotiated after

Straight answers

Why is my own compensation the first thing they adjust?

Because a buyer must pay a doctor to handle your caseload after you leave, and that wage comes straight out of the earnings they're purchasing. A defensible, market-based DVM comp normalization is the difference between an EBITDA that holds and one diligence marks down.

The multiples I hear about sound too good to be true. Are they real?

For well-run practices with recurring revenue and associate depth, the sector really has traded high — but those multiples are underwritten on normalized earnings, not reported ones. The prep exists to make sure your normalized number is strong and defensible enough to earn a number in that range.

Isn't this what the buyer's QoE firm does anyway?

They do it to protect the buyer, and their assumptions run conservative. Sell-side prep runs it first, on your side, so you bring defensible numbers rather than accepting theirs.

How far ahead of a sale should we start?

Ideally 6–12 months, so there's time to firm up wellness-plan accounting and add or document associate coverage that reduces how much the practice leans on you.

Free 20-minute books assessment

We'll show you the five things we'd fix first in your books — useful whether you hire us, hire someone, or do neither.

Talk to Sales

Or call us directly: +1 786 789 0969